MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,234,525 | -47.7% | 159,495 | -46.6% | 0.01% | -36.4% |
Q4 2022 | $4,276,543 | +298.9% | 298,850 | +611.5% | 0.01% | +266.7% |
Q3 2022 | $1,072,000 | -10.2% | 42,000 | -0.3% | 0.00% | 0.0% |
Q2 2022 | $1,194,000 | -88.2% | 42,106 | -80.0% | 0.00% | -83.3% |
Q3 2021 | $10,160,000 | – | 210,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |